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Abstract
This article is to present the concept of the electronic prescription model, taking into account legal regulations and technical solutions. Nowadays 
important changes have happened. In 2018, a law package regarding e-prescriptions was introduced in Poland that creates a new tool (electronic 
prescription) in the Polish market. Homogeneous tools enabling the security and integrity of e-documents and the approval of electronic signatures 
and seals are particularly important for the operation of the e-prescription. To enable the transmission of e-prescriptions it is required to join basic 
information and communications technology (ICT) system that supports e-prescribing to the main electronic identification system called Identifica-
tion Electronic Node. In order to implement the e-prescription model, the lanuching of electronic medical records is indispensable. In most EU coun-
tries the e-prescription is implemented with the interchange standard of medical records called Health Level Seven (HL7). In terms of identification 
and authentication in e-prescribing, the eIDAS regulation plays a significant role. The electronic prescription has long been used in many countries, 
among which Sweden was one of the earliest (Sjunet system). Patients, physicians, pharmacies and the state will all benefit from the implementa-
tion. Ultimately, prescribers would have to use tools that will make it possible to ensure the confidentiality, integrity and credibility of transactions.
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Przygotowanie do wydania elektronicznego finansowane w ramach umowy  
641/P-DUN/2018 ze środków Ministra Nauki i Szkolnictwa Wyższego  
przeznaczonych na działalność upowszechniającą naukę.
1. The objective of the article
This article is to present the concept of the electronic 
prescription model (e-prescription) in view of EU and 
national regulations, and the legal and technical solu-
tions necessary for its functioning, as well as to explain 
the concepts related to identification and to trust servic-
es. New regulations have introduced a number of legal 
institutions and concepts related to them – specifically, 
the concept of trust services, the use of which is neces-
sary to launch and develop the e-prescription project, 
i.e. creation of electronic signatures, electronic seals, 
electronic time stamps and registered electronic delivery 
services.
2. Prescription – definition and types 
A prescription is a written instruction directed to a phar-
macist, issued by an authorized entity under the binding 
regulations [1]. It concerns mainly medicines and medi-
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cal devices or foodstuffs intended for particular nutrio-
tional uses.
The content of the prescription (also an electronic 
prescription) is specified in the regulations. The data that 
are necessarily to be included in each prescription are:
1) patient data (name, surname, address, patient ID, etc.);
2) data regarding the entity where the prescription was 
issued or the person who issued the prescription (ad-
dress, name, identifier of the service provider, etc.);
3) data regarding the person issuing the prescription 
(name, surname, employee ID, employee signature, 
etc.);
4) data regarding the prescribed medicinal product, 
foodstuff intended for specific nutritional uses or 
a medical device (commonly used name or trade 
name, drug form, dosage, quantity, etc.);
5) data regarding the date of executing the prescription 
(issue and execution);
6) a unique number identifying the prescription (trans-
mitted by the ICT system or the director of the 
voivodship branch of the National Health Fund (Pol. 
NFZ);
7) marking indicating for whom the prescription is is-
sued if the prescription is written out for a relative 
(Art. 96a) [1, 2].
The prescription is part of medical documentation, 
but also a self-functioning document and has an effect 
for both the patient who receives the funds necessary 
for therapy, and for the health care system – in the 
case of therapy financed or co-financed from public 
funds. Therefore, it is of utmost importance that the 
substances ordered under the prescription go to people 
correctly diagnosed and that they are issued by appro-
priately authorized entities. This is to prevent a situation 
where some of the preparations purchased on their basis 
be sent to unauthorized persons, or even to feed their 
circulation on the black market (including psychotropic 
drugs, steroids).
Based on the type of media on which the prescrip-
tions are issued, we can distinguish paper and comput-
erized prescriptions (the name proposed by the authors 
of the article). Electronic prescriptions (e-prescriptions) 
constitute a separate category because their functioning 
requires a properly developed and functioning IT system.
A paper prescription is a traditional medical document 
containing elements required by law, which are necessary 
for its correctness and for it to be admitted to marketing. 
The entities authorized to issue a prescription are: a doc-
tor, a dentist, a doctor’s assistant, a senior doctor’s assis-
tant, and in the case of certain predetermined medicines 
and medical devices (excluding foodstuffs intended for 
specific nutritional uses), a nurse and midwife [1]. The 
paper prescription model is based on the presupposition 
that the person who signed the prescription is actually 
the person whose name appears on the seal and is enti-
tled to issue the document. In addition, each prescription 
written out to a patient should be related to their medi-
cal records. In practice, it is very difficult to verify the 
identity of the person signing the prescription, as well as 
verify their rights, both in relation to prescribing a given 
medicine and the correctness of the reimbursement for 
a drug. In conclusion, it should be noted that – apart from 
the substances written out – an integral part of the pre-
scription is the seal and signature of the person issuing 
it. Also, the medium and information contained in paper 
medical documentation form a coherent whole.
Computerized prescriptions, on the other hand, are 
those that operate in electronic form, but the condition 
for marketing them is to change their form from elec-
tronic to paper. They are most often defined in programs 
that support keeping electronic documentation by enti-
ties providing health services. They allow one to print 
the prescription in accordance with the formula defined 
in the regulations. However, in order for it to be admitted 
to marketing is it having appropriate seals of the institu-
tions, codes and, above all, a handwritten signature by the 
authorized person together with an individual seal stating 
the powers of the signer. In this case, we are dealing with 
a paper prescription, generated with the help of IT tools.
The basic difference between a paper and electronic 
prescription is related to the fact that in the case of the 
former we deal with a single document consisting of 
the seal and signature of the person creating the docu-
ment – any corrections or additions are possible in the 
cases provided by law, and they do not affect the validity 
of the document.
In the latter case, the signature is related to the content 
(to the data signed) in such a way that any subsequent 
change of data will be recognizable. In this concept, the 
electronic signature placed on the prescription is uniquely 
assigned to the signer, which makes it possible to deter-
mine their identity. In contrast, an identity confirmation 
system (that could be created) should be a system that 
would be separate from the document itself, operating in 
such a way that any interested entity could determine the 
identity of the person signing the document. Also, a sys-
tem needs to be created that would confirm the powers of 
the person issuing the prescription at the time of issuing 
it, i.e. a person authorized to practice, which by law is in-
dicated as a necessary requirement to issue a prescription.
3. Electronic prescription
3.1.  Implementation of the concept of the e-prescription  
in Poland
In force since January 2012, the act on the health informa-
tion system is one of the most important documents pav-
ing the way for solutions within the area of e-health [3]. 
The regulations adopted therein enabled the development 
of the electronic medical record system, data authoriza-
tion system, electronic referral (e-referral) or electronic 
prescription (e-prescription). The scope of practical func-
tionalities of the electronic prescription and its planned 
introduction to general use on 1 January 2020 is to be 
a key condition for improving the organization of the 
treatment process in our country – in relation to both 
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residential and outpatient care as well as health services 
provided by remote care services (e.g. teleconsultations).
The widespread introduction of the electronic pre-
scription system is associated with a number of benefits 
for the various interested groups in the healthcare system. 
From the patient’s perspective, the most important thing 
is to overcome the problem of illegibility of prescriptions, 
saving time, increased safety of therapy, the possibility of 
better coordination of the treatment process and improv-
ing the care of chronically ill patients. The entity issuing 
the electronic prescription saves its time and reduces the 
costs associated with issuing prescriptions in paper form. 
In turn, the entity executing the prescription acquires 
full legibility and credibility of the prescription, which 
simplifies the process of its execution. For the healthcare 
system, this solution means, first of all, sealing off the 
prescription system and drug circulation, obtaining strict 
control over the turnover of reimbursed drugs, current ac-
cess to information on replacement medicines, and the 
possibility of linking individual groups and types of drugs 
to the epidemiology of specific diseases in the population 
[4]. Some authors, however, show more reservation to-
wards the idea of the electronic prescription model in Po-
land, in their opinion resulting from fear of an imprudent 
growth of remote services in health care, as an alternative 
to traditionally understood medical art requiring a direct 
contact between the doctor and the patient [5]. 
Regarding the effectiveness of the implementation 
of the e-prescription system, Poland is unfortunately oc-
cupying a distant position. There are countries that have 
long used the electronic prescription transfer in their 
healthcare systems. It is worth recalling that as early as 
in 2008, the European Commission clearly stressed its 
expectations for the member states to make more pro-
gress in introducing e-prescriptions [6]. At that time, 
electronic prescriptions already functioned in several 
European countries. Looking at the facts, our delay in 
this area is even more vivid – Great Britain has been us-
ing e-prescriptions since 2005, Denmark since 1992, and 
the first works on the implementation of electronic pre-
scription transfer in Sweden began in 1983. Moreover, 
even developing countries formerly referred to as ‘Third 
World countries’ (e.g. India or Brazil) currently use such 
systems, and Russia launched e-prescriptions in 2014 [7].
In February this year, another pilot study of e-pre-
scriptions began in the Polish towns of Siedlce and Ski-
erniewice, while on 18 April, 2018, a package of legisla-
tive acts introducing a widespread use of e-prescriptions 
[2, 8] came into force. By the end of 2018, all pharmacies 
and pharmaceutical agencies in Poland are to have been 
included in the integrated P1 platform. The process of 
creating the electronic P1 platform is supervised by the 
Health Care Information Systems Centre. The goal of the 
undertaking is to construct a tool for collecting, analyz-
ing and sending electronic data on medical (and other) 
incidents to the extent compliant with the Act of 28 April 
2011 on the information system in health care [9]. Then 
the e-prescription module will be activated in the treat-
ment entities [10]. 
3.2.  E-prescription as an element of electronic medical 
documentation 
Electronic medical documentation (Pol. EDM) and e-
prescription, which it is a part of, are solutions that are 
dynamically entering the Polish information system health 
care (Pol. SIOZ) [3]. The advancement of technological 
solutions currently available on the market enables the 
introduction of fast and secure systems, allowing the pro-
cessing of large amounts of data and information in a short 
time, in this way facilitating the introduction of solutions 
that have been awaited by patients and the medical com-
munity for years. These include e-prescriptions and other 
electronic medical documents that are required to receive 
a service or product (e.g. e-referral or e-orders).
As a medical document, the e-prescription is regu-
lated by both national and international law. Work is un-
derway on the possibility of using the e-prescription, as 
well as other electronic medical documents, throughout 
the European Union (EU), regardless of the place where 
the document was issued. The possibility of patients ben-
efiting from cross-border healthcare was regulated in the 
European Parliament and Council’s Directive 2011/24/
EU of 9 March 2011, on the application of patients’ rights 
in cross-border healthcare [11]. However, the Commis-
sion’s Implementing Directive 2012/52/EU of 20 De-
cember 2012, specifying the measures facilitating the 
recognition of medical prescriptions issued in another 
Member State [12], lists the minimal elements that must 
be included in medical prescriptions for them to be rec-
ognized in another EU country.
Since the e-prescription is an electronic document, 
it is appropriate to clarify the definition of an electronic 
document, which differs in Polish and European (EU) 
law. The Polish act on the computerization of entities 
performing public tasks [13] defines the electronic docu-
ment as “a separate data set confined in a specific inter-
nal structure and stored on an IT data medium” (Art. 3.2), 
where the IT data medium is “a material or device used 
to record, store and read data in digital form” (Art. 3.1) 
[13], while the definition adopted by the Regulation No. 
910/2014 of the European Parliament and of the Coun-
cil of 23 July 2014 on electronic identification and trust 
services for electronic transactions in the internal market 
and repealing Directive 1999/93/EC, Electronic Identi-
fication, Authentication and Trust Services, eIDAS [14] 
is slightly wider. It allows free use of the technologies 
and is not limited to one type of medium. According to 
it, an electronic document is understood as “any content 
stored in electronic form, as a text, visual, audio or au-
diovisual recording”, thus creating the freedom to use 
any technology for data storage [14]. Additionally, the 
e-prescription can be included in the medical documen-
tation of an individual, external type, which by defini-
tion is intended for the patient using medical services of 
a given provider [15].
Due to the fact that the e-prescription will be pro-
cessed on the P1 platform and the Patient Internet Ac-
count (Pol. Internetowe Konto Pacjenta, IKP) module, in 
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the future, it will correspond to the standard of electronic 
information exchange in the medical environment (The 
Health Level Seven, HL7), adopted in the document “Po-
land Implementation of the National HL7 CDA (Clinical 
Document Architecture)” [16]. The application of this 
standard is to help IT service providers to standardize 
templates and procedures for creating, storing and send-
ing electronic documents between various entities [8, 16].
3.3. Features of the electronic prescription
In a standard system (of some EU countries; see Chap-
ter 7. Electronic prescription in other countries), e-pre-
scription is the electronic final document of an informa-
tion system (national or regional), which in addition to 
the content relevant for the prescription, also contains 
technical solutions that enable, i.a.:
• determining the identity of the person signing the 
e-prescription and confirming the right of that per-
son to issue such documents and writing out specific 
medicines (including the contract with the NHS (Pol. 
NFZ) for the provision of services and issuing pre-
scriptions for reimbursed drugs);
• detection of all data changes (integrity) following its 
issue;
• the impossibility of denying the signature by the au-
thor and the seal issued by the institution;
• the verification of the signature of the person who 
signed the prescription and the entity under which 
the signer provides services, by any interested party 
(person or institution).
The e-prescription as a carrier of health data must be 
properly secured. It is part of the medical documentation, 
but it should be operated by a separate IT system. There-
fore, it is necessary to ensure cooperation between both 
systems, because the electronic prescription, as part of 
the medical documentation, must be compatible with the 
documentation functioning in the therapeutic entity.
3.4. Security of the e-prescription 
Multidirectional works are underway in the EU, whose 
aim is to introduce uniform laws regarding the identifi-
cation of all persons and institutions using information 
systems to process electronic documents [14] – including 
electronic medical documentation. So far, uniform solu-
tions have been introduced regarding the creation, secur-
ing and trading of electronic documents as well as the 
possibility of verifying the origin of the document and 
its creator or institution that has the right to disseminate it. 
These solutions have been introduced by the eIDAS Reg-
ulation [14], together with national laws that supplement 
its provisions [17]. The safety of personal data, including 
patient data, has also been uniformly regulated through-
out the EU (RODO) [18]. The health care sector is also 
covered by the provisions of the Act of 5 July 2018 on 
the National Cyber Security System [19] – developed 
on the basis of the Directive of the European Parliament 
and of the Council (EU) 2016/1148 of 6 July 2016 on 
measures for a high common level of security of network 
and information systems in the territory of the European 
Union [20]. The purpose of the provisions of the Act on 
the national cyber security system is to ensure the resil-
ience of information systems, including health care, to 
activities that violate the confidentiality, integrity, avail-
ability and authenticity of the data processed or related 
services offered by these systems.
The electronic prescription is subject to the safety 
standards contained in the eIDAS Regulation. Both the 
electronic identification system and the electronic means 
of identification are protected – meaning a “tangible or 
intangible unit containing person identification data and 
used for authentication purposes for an online service” 
(Article 3.2) [14]. There are three security levels of the 
two elements mentioned above (system and means of 
identification): low, medium and high. The higher the 
level, the more secure the security mechanisms are, and 
the data you want to access receive the status of sensi-
tive and confidential data. [21]. Due to the level of data 
sensitivity in health care, a high level of security is rec-
ommended in electronic identification systems [22]. The 
high level is characterized by a wide range of trust in 
the identity of people and concerns technical specifica-
tions, procedures and standards. This is to prevent the 
risk of impersonating a person or modifying their iden-
tity. At this level, it is recommended that two or more au-
thentication factors (i.e. characteristics of a given person 
with a confirmed origin and relationship) contained in 
the electronic identification and the obligation for all EU 
countries to recognize this tool [2].
In entities that carry out medical activities (e.g. en-
terprises, independent public health care units [Pol. SP 
ZOZ]), there may be ICT systems that are subject to the 
act on the computerization of entities performing public 
tasks [13]. An ICT system is an IT system created to sup-
port a given area of health protection [3]. If a given ICT 
system allows access to the patient’s electronic medical 
records, persons who want to access these data must un-
dergo the authentication process – confirmation of the 
origin and integrity of verified electronic data assigned 
to the identity. The authentication process includes: 
1) “electronic means of identification issued in the elec-
tronic identification system connected to the national 
electronic identification node; 
2) electronic means of identification issued in the noti-
fied electronic identification system, or
3) data verified by means of a qualified electronic signa-
ture certificate, if these data allow the identification 
and authentication required for the provision of the 
online service” (Article 20a.1) [13].
In conclusion, the e-prescription model and the sys-
tem supporting this tool to ensure data security must meet 
the many requirements contained in Polish and EU law. 
4. Models of e-prescriptions
One of the necessary conditions for the electronic pre-
scription to be implemented in a given area is the earlier 
launch of electronic health records (EHR). In addition to 
the e-prescription, it provides such services as a patient 
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portal, authorization services or access to remote medical 
consultations. An e-prescription is defined as prescribing 
medicines using software and by an authorized entity, for 
the purpose of dispensing medicines in a pharmacy after 
sending it electronically [23]. An important feature of the 
e-prescription is the fact of recording the data on the is-
sued drug in the patient’s medical records, and for this it 
is necessary to implement the EHR system.
Following their visit and authorization from the GP, the 
patient receives an entry in their medical records about the 
medicine that has been prescribed. Then, in the pharmacy, 
also after authorization, the patient receives the prescribed 
medicine, and the fact of its release is recorded in the 
electronic documentation (EHR). This enables all medi-
cal entities to view, among other things, the history of the 
medicines and pharmaceuticals issued and purchased. In 
this model, the payer of services (e.g. the National Health 
Fund, Pol. NFZ) also has information on the entire his-
tory, not only the medicines issued, but other medical ser-
vices. The patient has the opportunity to view their history 
through the patient’s portal, which uses the data stored in 
the EHR as an integrated ‘data warehouse’. This solution 
is possible after at least two conditions have been met:
1. in the area where EHR has been implemented, there 
is a uniform standard for recording and transmitting 
medical data in an electronic form. The standard for 
electronic information exchange in the medical envi-
ronment is dominant (The Health Level Seven Ver-
sion 3, HL7 v 3.0);
2. IT systems of service providers have the option of re-
cording data in the XML format (Extensible Markup 
Language), which ensures interoperability of medical 
documents in electronic form.
In the case of the HL7 v. 3.0 standard, it should be 
mentioned that the minimum condition for the implemen-
tation of an electronic document is the development of 
HL7 CDA (Clinical Document Architecture) templates, 
and the optimal procedure is the development of an in-
tegrated reference model (Reference Information Model, 
HL7 RIM) based on a set of minimum data (Minimum 
Data Set, MDS). HL7 RIM gives the possibility to de-
velop the entire system of circulation and storage of 
universal medical data for all entities interested in the 
population’s medical data. What is also indispensable 
is system integration and for this purpose technological 
rails, or tools used for transporting data packets (mes-
sages) are used. In terms of system integration, two types 
of rails are used:
1. IHE (Integrated Healthcare Enterprises), which de-
fines and coordinates existing Digital Imaging and 
Communications in Medicine (DICOM) and HL7 
standards to support specific medical requirements 
related to patient care. 
2. XDS (eXtended Data Distribution System), which is 
a software solution based on an extended communi-
cation protocol (File Transfer Protocol, FTP), in the 
client-server architecture used to create a data trans-
mission network.
The flow of documentation in the context of HL7 is 
shown in Figure 1.
Figure 1 presents a chart of the electronic documen-
tation flow based on HL7 RIM and the IHE/XDS com-
Figure 1. The flow of documentation in the context of HL7.
Source: Own elaboration.
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munication system. The effect of modelling based on 
the HL7 standard is a set of XML Schema files, which 
describe what the messages should be like.
The implementation of the e-prescription based on 
the HL7 model is essential in the context of cross-border 
medical care. In most countries of the present European 
Union, the e-prescription has already been implemented 
and HL7 is used as the standard for the exchange of 
medical records. In 2018, the European Commission 
launched the initiative of the e-health digital infrastruc-
ture (eHealth Digital Service Infrastructures, eHDSI, 
e-health DSI). This is the initial implementation and run-
ning of services related to the cross-border exchange of 
health data under the Connecting Europe Facility (CEF). 
eHDSI configures and initiates the implementation of ba-
sic and general services, for cross-border care of patients, 
and the issuing of e-prescriptions. The implementation 
of general services is necessary for data exchange at the 
national level, while basic services – at the EU level [24]. 
Together, these services enable the provision of cross-
border e-health information services [25]. The above-
mentioned documents show diagrams for different cases 
of individual medical events. One of them is the purchase 
of the medicine in a different country than where it was 
prescribed.
The primary purpose of the Electronic Patient Re-
cord (EPR) in the eHDSI model is to provide key pa-
tient health data during the provision of an unscheduled 
medical service, which can affect treatment. This type of 
events may unfold in the following way [23]:
1. The entity is uniquely identified and authenticated in 
its local system, according to its profile.
2. The patient identifies himself/herself in the system.
3. The entity checks and confirms the identification pro-
vided.
4. Once the patient has been clearly identified through 
the appropriate authorization system, the entity may 
become familiar with their health data.
5. Before any information is provided to the entity, the 
patient must give their voluntary consent. Refusal to 
give consent is possible only in the case of protection 
of the vital interest of the patient or other person in 
an emergency, when the patient (the data subject) is 
physically or legally incapable of giving consent.
6. Information from country A should be presented to 
other entities in an orderly manner and based on na-
tional standards that are legible for country B. The in-
formation displayed by the entity in country B should 
be understandable (therefore, the available coding 
systems should be used).
7. A copy of the original information from country 
A may be shown to the entity in country B, if neces-
sary (e.g. in the PDF version).
Such solutions can be used only when the imple-
mented medical documentation in electronic form will be 
based on a uniform and known standard. When design-
ing the model of the e-prescription in Poland, it is worth 
considering the provisions regarding the recognition of 
this document in European Union member states (defined 
i.a. in the Commission Implementing Directive 2012/52/
EU of 20 December 2012 establishing measures facili-
tating the recognition of medical prescriptions issued in 
another Member State) [12]. The e-prescription model 
developed by the Centre for Healthcare Information Sys-
tems (Pol. CSIOZ) is based on the HL7 CDA standard. 
The templates of electronic documents were developed 
after prior consultations of “Version 1.2 of business rules 
and validation of electronic medical documents”. The 
templates concern: a prescription issued by a pharmacist 
at a pharmacy, a prescription for direct import, and a pre-
scription that meets the requirements for a refund [26]. 
According to the assumptions published by the CSIOZ 
[9], the e-prescription flow will include the following:
Step 1. The doctor issues and digitally signs an 
e-prescription.
Step 2. The patient receives a print-out of the 
e-prescription or electronically as an e-mail or SMS with 
a 4-digit code.
Step 3. The patient arrives at the pharmacy.
Step 4. The pharmacist scans the code from the print-
out or from the telephone.
Step 5. The patient receives the medication.
5.  Trust services. The role of e-signature, e-seal, and other 
legal and technical solutions 
In addition to EU laws that set out the measures facili-
tating the recognition of medical prescriptions issued in 
a Member State other than the Member State of their exe-
cution [12], an important role is played by the laws on the 
tools required for the secure circulation of electronic doc-
uments (eIDAS). These tools are trust services, defined as 
electronic services, usually payable, and including:
a)  “Creation, verification and validation of electronic 
signatures, electronic seals or electronic time stamps, 
electronic registered delivery services and certifi-
cates related to these services; or 
b)  creation, verification and validation of website au-
thentication certificates; or
c)  maintenance of electronic signatures, seals or related 
certificates with these services” [14].
A standard paper prescription must be signed with 
a handwritten signature (entailing legal consequences), 
and therefore, an e-prescription should also be signed 
with an electronic signature guaranteeing the recognition 
of the document in a legal context.
The electronic signature is directed to natural per-
sons and is defined as “data in electronic form, which 
are attached or logically linked with other data in elec-
tronic form and are used by the signer as a signature” 
(Art. 3.10) [14]. These days, in the health care sector in 
Poland, a medical specialist has at their disposal three 
methods of electronic signing, namely using a trusted 
signature, a qualified electronic signature, or using a tool 
(certificate) made available by the teleinformation sys-
tem of the Social Insurance Institution [Pol. ZUS, 27].
The electronic signature includes three main types 
regulated in the territory of the European Union. How-
ever, in the relations between the service provider and 
the service recipient (physician – patient), the qualified 
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electronic signature can be validly used. It ensures in-
tegrity with the document and the identification of the 
signer, ensures the visibility of subsequent changes to the 
document, is subject to maintenance and validation, has 
a qualified certificate, and yields legal effects equal to 
the handwritten signature. The method of submitting this 
signature is only via a qualified device (e.g. an electronic 
card reader connected to a computer) [14, 28]. 
In addition, other electronic tools are dedicated to 
electronic documents that ensure their security, such as 
the electronic seal, time stamp or the service of registered 
electronic delivery. In some cases, the electronic seal will 
be used in the aspect of e-prescriptions – depending on 
the model of the system. Until the introduction of the 
eIDAS regulation, neither the European electronic sys-
tem nor the national electronic seal had been defined or 
regulated. As stated in the binding EU regulation: “the 
electronic seal refers to data in electronic form added to 
other data in electronic form or logically related to them, 
to ensure the authenticity of their origin and integrity of 
related data (Art. 3.25)” [14].
It is worth clarifying here that the electronic signa-
ture and seal resemble their paper counterparts only in 
name. The idea of the digital signature and seal is based 
on the creation of the mechanism of the so-called trusted 
third party. The idea is that, apart from the entities using 
digital signatures, there is an entity that issues certificates 
confirming the identity of certain individuals and institu-
tions. These institutions are trust service providers who 
had to undergo the accreditation process by the ‘con-
formity assessment body’ checking compliance with the 
requirements of the eIDAS regulation. The ‘conformity 
assessment body’ issues relevant reports confirming the 
role exercised by the suppliers of the reports, which can 
be requested by the supervisory body at any time during 
the audit [14]. 
Particularly important mechanisms enabling the use 
of e-prescriptions are the uniform tools that – on the one 
hand – ensure the security of e-documents, their interop-
erability and – on the other – the acceptance of electronic 
signatures and seals throughout the EU. The basic prin-
ciple adopted was that every country providing access 
to services via ICT networks must provide this access to 
all EU citizens, and if these countries have introduced 
the possibility of their citizens receiving identification 
means, they must also be recognized throughout the en-
tire European Union.
Additionally, it is worth mentioning that the eIDAS 
regulation contains attachments (called requirements), 
which describe in detail i.a. what standards must be met 
by the electronic seal and signature (along with the cer-
tificates assigned to them) to ensure safety of their use. 
These requirements are guidelines for creating trust ser-
vices and systems that support these tools [14].
Returning to the tools recommended by the eIDAS 
regulation, the electronic time stamp “are data in elec-
tronic form that bind other data in an electronic form 
with a certain time, being evidence that these other data 
existed at a given time” (Article 3.33), while electronic 
registered delivery service “refers to a service that allows 
data to be sent between third parties electronically, and 
that provides evidence related to the use of transmitted 
data, including proof of sending and receiving data, and 
protecting transmitted data against the risk of loss, theft, 
damage or any unauthorized change” (Article 3.36) [14].
The provisions included in the eIDAS regulation do 
not create restrictions on the technologies used in trust 
services, which gives the opportunity to apply innova-
tive technologies such as cloud computing. The compa-
nies that have used this technological solution are, for 
example, SkIDentity and FutureID. They offer – in the 
form of services – the architecture of electronic delivery 
and electronic signature tools, seals and certificates. This 
means that all data relating to these elements is stored 
outside the place of service provision (e.g. a pharmacy), 
in a secure manner. Experts estimate that over the years 
such solutions will become more and more popular – in-
evitably, also in the health care sector [29].
The eIDAS regulations do not apply to the provision 
of trust services used only within closed systems operat-
ing under national law or agreements concluded by a spe-
cific group of participants (Article 2) [14].
In the law on e-prescription [8], the Polish legislator 
allows use of the ZUS tool to sign e-leaves, which cur-
rently operates in the internal information flow system 
serving the authentication of electronic medical records, 
in this case e-prescriptions contained in an open, external 
system, thus creating a third form of confirming identity, 
along with the trusted ePUAP profile and qualified sig-
nature [30].
There is some inconsistency with the law, namely 
the fact that the internal tool confirming ZUS identity 
does not meet the requirements of the eIDAS regulation, 
and so should not be used as a universal tool for signing 
electronic documents (e-prescriptions) outside the parent 
institution, i.e. in an open system with other entities.
6.  New tools and changes within the structure  
of the national identification system
As of today, the Polish legislator allows three methods 
mentioned above to sign electronic documents [1]. How-
ever, the draft law introduces new tools that will allow 
providing better standards in the scope of security of 
the content contained in e-prescriptions, and the greater 
universality of free-of-charge solutions, available both to 
entities authorized to issue and to receive prescriptions. 
6.1. ID card with an electronic layer 
In a few months, a multifunctional identity card is ex-
pected to enter into force (planned starting from March 
2019). It is to constitute a free-of-charge, state-owned 
electronic identification method. This document will be 
a clear and undeniable confirmation of the identity of 
the citizen. It will also be used for the authentication in 
e-services used in public administration and for signing 
electronic documents, as well as for confirming pres-
ence in ICT systems. The new ID will have an ICAO 
application (travel document with the biometric feature 
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called ‘face image’) and electronic data, which together 
with data known only to the holder of this ID, will allow 
to authenticate it in ICT systems used to provide online 
services, as well as for signing electronic documents 
with an electronic signature [31]. Once the new ID has 
come into force, a personal signature will appear, i.e. an 
advanced electronic signature within the meaning of the 
eIDAS regulation, and importantly, it will be able to be 
submitted without the need to access the Internet (using 
a reader). The advanced electronic signature has the fol-
lowing features: uniquely assigned to the signer, allows 
determining the identity of the signer, submitted using 
data known only to the signer, and making it possible 
to notice any subsequent change in the signed docu-
ment. Using a personal electronic signature in a public 
entity will have the same effect as a handwritten signa-
ture, and in the case of another entity the same effect will 
arise, provided the subject and the holder of the ID card 
consent to it. Notwithstandingly, the new ID will allow 
the placement of a qualified electronic signature certifi-
cate issued by commercial suppliers [31]. Three func-
tionalities of the new ID necessary for the functioning of 
the e-prescription are: 
• authentication of the identity card holder in telein-
formation systems (identification and authentication 
certificate); 
• confirmation of the presence of the holder of the ID 
card at a specified time and place or participation in 
services (certificate of presence confirmation);
• placement of a personal signature (personal signature 
certificate) [31]. 
According to the new concept, a citizen choosing an 
ID card containing an electronic layer will gain a means 
of electronic identification (an intangible unit containing 
data identifying the person, needed for the authentication 
process for online services) called the ‘personal profile’, 
and the option of creating an electronic signature (‘per-
sonal signature’) fulfilling European Union standards. In 
addition, the name of another existing electronic identi-
fication means, ‘trusted ePUAP profile’ will be changed 
to ‘trusted profile’, and the currently implemented tasks, 
will be excluded – in legal and technical terms – from 
the responsibilities of the ePUAP [Electronic Platform of 
Public Administration Services]. Also the functionality 
of covering electronic documents with ‘a signature con-
firmed by a trusted profile’ will be eliminated. A separate 
‘public electronic identification system’ will be created 
(teleinformation system), whose task will be to support 
two means of electronic identification, ‘personal profile’; 
‘trusted profile’ and ‘trusted signature’ tool, which will 
replace ‘signature confirmed with a trusted profile’. The 
authenticity of a trusted signature placed on an electronic 
document will be guaranteed by an electronic seal of the 
minister in charge of computerization. ‘Trusted profile’ 
will be a means of electronic identification ensuring 
a medium level of trust (security), and so applicable to 
most online services, but not in medical records and not 
outside of Poland. Its use will require providing the login, 
password and entering the code received on the user’s 
mobile phone. Submission of the ‘trusted signature’ will 
be possible using the ‘trusted profile’ as well as the ‘per-
sonal profile’. Under the new rules, the public entity will 
be able to authenticate the individual using the ‘trusted 
profile’ and ‘personal profile’, while non-public entities 
will be able to authenticate only using the ‘personal pro-
file’. The ‘public electronic identification system’ will be 
integrated with the ‘national node’, in this way impos-
ing on each entity wishing to integrate its own service 
platform with this ICT system, the requirement of rec-
ognition of the authentication of a physical person using 
a foreign electronic identification means [31]. 
6.2. Electronic identification system 
In order to send e-prescriptions, an electronic system 
supporting electronical prescriptions needs to be con-
nected to the Electronic Identification Node. In short, 
this node refers to the structure as such together with the 
entire digital architecture, which in one place integrates 
electronic identification systems (e.g. Trusted Profile), 
ICT systems of public services (e.g. ePUAP, ZUS PUE, 
RUM NFZ) and – optionally – public attributes (e.g. 
PESEL) – defined as individual identifiers serving to 
verify the identity of a natural or legal person, determined 
in accordance with national law, and which can be used in 
qualified certificates if they do not interfere with cross-
border interoperability [14]. In addition, the use of both 
identifiers and commercial attributes (offered by banks 
and other entities for use in the public electronic identifi-
cation system) is allowed [32].
6.3. Medical specialist card 
From the beginning, the implementation of the informa-
tion system in health care entailed the issuing of special 
tools, i.e. KSM (Medical Specialist Card), KSA (Admin-
istrative Specialist Card) – for service providers and for 
e-KUZ (Electronic Health Insurance Card) – for patients, 
which would enable both issuing e-prescriptions as well 
as their reception. It should be noted here that e-KUZ 
is a different tool to the existing European Health Insur-
ance Card (EHIC), which indicates that you have health 
insurance. Simultaneously with the work on e-KUZ, the 
concept of a new ID with an electronic layer was imple-
mented. Unfortunately, both of these tools have remained 
only conceptual.
Legislative work is underway to create new docu-
ments with an electronic layer, i.e. “Rights to practise as 
a physician” and “Rights to practise as a dentist”. They 
are supposed to function in the form of polycarbonate 
cards with the dimension and security measures similar 
to the ID card. In the future, the right to practise as a doc-
tor or dentist will simultaneously constitute the Medical 
Specialist Card (Pol. KSM), and should therefore en-
able the identification and authentication of a medical 
professional for the purpose of providing healthcare ser-
vices. It is connected with the necessity of equipping the 
document with a microprocessor (or other data medium), 
which will make it possible for it to be assigned the func-
tionality of the electronic signature [33, 34].
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The launching of the e-prescription project must be 
preceded by activities that will result in equipping all 
the persons entitled with the tools necessary for signing 
(electronic signatures) and guaranteeing the integrity of 
the signed content and making it possible to verify its 
authenticity (electronic seals). The implementation of 
these tools is a necessity in order to make sure that the 
e-prescription concept is compliant with the solutions.
7. Electronic prescription in other countries
The electronic prescription has long been used in many 
developed countries. Sweden is the country where the 
process of implementing electronic prescriptions started 
very early. Work on the implementation of this solution 
had begun as early as in 1983, while the launch of the 
advanced system took place in 2004 [35].
7.1. The way the e-prescription system works in Sweden
In Sweden, Sjunet is a dedicated system for the process-
ing of e-prescription data. Most pharmacies and entities 
providing health services have access to this network 
(which does not require connection to the Internet), but 
the network can be accessed also by other units [36].
The prescription is issued in an electronic form by 
a physician, by means of an electronic system, from 
where it is immediately sent to the central database or 
to the pharmacy indicated by the patient. If the docu-
ment is sent to the database, the e-prescription can be 
bought at any pharmacy (within the country). In order to 
execute the e-prescription, the patient’s identity must be 
confirmed by the pharmacist. The advantage of sending 
e-prescriptions to a pharmacy indicated by the patient is 
that the pharmacist can prepare the prescribed product 
earlier. The fact that the network is not connected to 
the Internet contributes to securing the processed data, 
thanks to which only the issuing persons and pharmacy 
employees have access to them. In addition, the crea-
tion of a central database allows access to information 
on e-prescriptions previously issued to a given patient, 
which in turn, avoids the repeated prescribing of the same 
preparations [36, 37].
A simplified diagram of the functioning of the Swed-
ish e-prescription system is shown in Figure 2.
The successful implementation of Sjunet was mainly 
due to the advanced level of digitization of entities pro-
viding health services and to the close cooperation of 
the above-mentioned facilities (especially at the local 
level) with the state network of pharmacies (Apoteket 
AB) holding exclusive rights to trade in medicines un-
til 2010, which enabled the creation of a national da-
tabase containing data on the execution of e-prescrip-
tions. In addition, the factors that contribute to the Swedish 
e-prescription system being recognized as one of the 
most effective solutions are: the creation of the Sjunet 
network and training for medical personnel (mainly doc-
tors) on proper document completion, as well as training 
for patients aimed at increasing public awareness of the 
benefits of implementing the planned solution [38], [36]. 
Thanks to the multi-stage implementation of the system 
of e-prescriptions, they constitute about 90% of all pre-
Figure 2. Diagram of the functioning of the Swedish e-prescription system.
Source: Own elaboration.
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scriptions issued by doctors in Sweden [39]. In addition, 
the study conducted in 2011 shows that the vast majority 
of patients in Sweden report positive experiences related 
to the use of e-prescriptions [37].
7.2. Electronic prescription in Spain
The e-prescription system operates also in Spain. In con-
trast to Sweden, the system created in Spain is decentral-
ized, which means that each region of the country has 
a separate solution for processing data on the aforemen-
tioned documents [35].
One of the best-functioning e-prescription systems in 
Spain is the ‘Receta XXI’ operating in Andalusia. This 
system can be accessed by primary care facilities, emer-
gency medical services and centres providing outpatient 
services – both within state and private health insurance), 
and includes electronic medical records containing 
medical data of patients acquired from the Diray system. 
Combining both systems allows continuous access to 
the history of patients’ diseases, which in turn facilitates 
writing out e-prescriptions [40].
The patient who comes to the doctor is obliged to pre-
sent a card (with an electronic layer) confirming the pos-
session of health insurance. The card enables access to 
the patient’s electronic record and confirmation of their 
identity, which is necessary for writing out the e-prescrip-
tion. The person writing out the document can also use 
a digital dictionary of medicinal products with informa-
tion on doses, mode of action and the use of individual 
substances, which is updated on a monthly basis [40].
The e-prescription issued by the doctor is stored in the 
Receta XXI system, while the Diraya system records data 
on the preparations given out to each patient. The e-pre-
scription can be executed by the patient in any pharmacy, 
subject to its affiliation to the system. In order to execute 
the prescription, it is also necessary for the patient to show 
the card enabling confirmation of their health insurance, 
which at the same time guarantees the pharmacist’s access 
to the system processing the data on e-prescriptions. In 
turn, the pharmacist is obliged to have a card identifying 
the pharmacy (confirming its affiliation to the system) [40].
There are three ways to write out prescriptions in the 
Spanish region of Andalusia. The first one is to complete 
the document in handwriting, and then introduce its 
content to the system. This method is particularly use-
ful for home visits. The second method is to write out 
the prescription in electronic form and print out its paper 
version, which is then passed on to the patient, and so 
its execution in the pharmacy takes place in a traditional 
way. The third method is to fill in the document in the 
Receta XXI system and send it to the central system, 
thanks to which it can be executed at any pharmacy (the 
pharmacist can access it through the system). In this case, 
it is also possible to print out a prescription for the patient 
in order for them to obtain information on dosage, for 
example; however, they do not need to present a printout 
in order to buy medicines in the pharmacy [40].
The diagram presenting the e-prescription system in 
Andalusia is shown in Figure 3.
The advantages of the implemented system include, 
above all: enabling patients to access the prescriptions 
issued for them (e.g. during a doctor’s check-up visit 
or at a pharmacy), increasing security and saving medi-
cal staff time. The success of the e-prescription system 
in Andalusia is also due to the gradual expansion of the 
area of operation of this network and the possibility of 
responding to emerging problems, as well as the creation 
of cooperation opportunities for systems used in various 
regions of the country [40].
Figure 3. Diagram of the functioning of the e-prescription system in Andalusia.
Source: Own elaboration.
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Conclusions
Taking into account the advancement of information 
technology, the introduction of the e-prescription system 
is simply inevitable. The implementation of the system 
will be beneficial to all entities in the medical services 
market, i.e. patients, the state participating in the reim-
bursement of the medicines, and the entities that write 
out the medicines. The introduction of the e-prescription 
model is unfeasible without a system serving the identifi-
cation of both the person entitled to issue e-prescriptions 
as well as patients entitled to use state funding. In ad-
dition, it is necessary to identify the medical entities in 
which services related to the issuing of the prescription 
were performed. Lastly, the entities issuing the prescrip-
tions must use tools that will ensure: 
• confidentiality – data protection against disclosure to 
unauthorized persons;
• integrity – securing data and electronic documents 
before the change;
• credibility – ensuring the possibility of identifying the 
entity issuing the e-prescription in the electronic world.
The e-prescription system must be fully compatible 
with the systems used by all entities maintaining medical 
documentation. Separate handling of electronic medical re- 
cords – one where the authorized entity will register 
medicines written out for the patient and another used 
to support the electronic prescription – is unacceptable. 
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